You just read:

The Canadian Pharmaceutical Company Duchesnay Inc. Sets for International Expansion Following the US Approval of its Morning Sickness Medication Diclegis® by the FDA

News provided by

Duchesnay inc.

09 Apr, 2013, 18:58 BST